Neurocircuitry of acupuncture effect on cognitive improvement in patients with mild cognitive impairment using magnetic resonance imaging: a study protocol for a randomized controlled trial.
Acupuncture
Cognitive function
MCI
Mild cognitive impairment
Neuroimaging
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
30 May 2019
30 May 2019
Historique:
received:
28
11
2018
accepted:
13
05
2019
entrez:
1
6
2019
pubmed:
31
5
2019
medline:
24
12
2019
Statut:
epublish
Résumé
Mild cognitive impairment (MCI) is defined as a decline in cognitive state with preservation of activities of daily living. Medications such as donepezil and rivastigmine have been commonly prescribed for MCI, but their use is controversial. Acupuncture has been widely used in Korea and has been shown to improve cognitive function. The aim of this study is to evaluate the efficacy of acupuncture for MCI and investigate the effect of acupuncture on structural and functional brain changes in patients with MCI. This study is a randomized, assessor-blinded, sham-controlled trial. Fifty participants with MCI will be randomly assigned to the acupuncture group (n = 25) or sham acupuncture group (n = 25). The acupuncture group will receive acupuncture treatment at nine acupuncture points (GV20, EX-HN1, bilateral LI4, and ST36) twice a week for 12 weeks. The sham acupuncture group will receive sham acupuncture treatment at the same points with non-penetrating sham needles. Both groups will be restricted from all other treatments for the improvement of cognitive function. The primary outcome measure is the Digit Span Test (DST). The secondary outcome measures are the Digit Symbol Substitution Test (DSST), Korean version of Montreal Cognitive Assessment (MoCA-K), Seoul Neuropsychological Screening Battery-II (SNSB-II), Beck Depression Inventory-II (BDI-II), State-Trait Anxiety Inventory (STAI), working memory (WM) task performance score, and structural/functional brain changes. Outcomes will be assessed at screening, baseline, 4 and 8 weeks, and after the end of treatment. We will also observe adverse events. In the statistical analysis, a full analysis set and per-protocol analysis will be performed. This randomized clinical trial aims to examine the efficacy of acupuncture treatment for MCI. Neuropsychological tests, psychological inventories for measuring depression and anxiety, and magnetic resonance imaging will be performed to investigate the underlying neurological mechanisms and the association between cognition, emotion, and brain networks following acupuncture treatment. The results of the trial will provide evidence supporting the efficacy of acupuncture and also add to the neurobiological understanding of acupuncture treatment for MCI. Clinical Research Information Service, KCT0002896 . Registered on 25 May 2018.
Sections du résumé
BACKGROUND
BACKGROUND
Mild cognitive impairment (MCI) is defined as a decline in cognitive state with preservation of activities of daily living. Medications such as donepezil and rivastigmine have been commonly prescribed for MCI, but their use is controversial. Acupuncture has been widely used in Korea and has been shown to improve cognitive function. The aim of this study is to evaluate the efficacy of acupuncture for MCI and investigate the effect of acupuncture on structural and functional brain changes in patients with MCI.
METHODS
METHODS
This study is a randomized, assessor-blinded, sham-controlled trial. Fifty participants with MCI will be randomly assigned to the acupuncture group (n = 25) or sham acupuncture group (n = 25). The acupuncture group will receive acupuncture treatment at nine acupuncture points (GV20, EX-HN1, bilateral LI4, and ST36) twice a week for 12 weeks. The sham acupuncture group will receive sham acupuncture treatment at the same points with non-penetrating sham needles. Both groups will be restricted from all other treatments for the improvement of cognitive function. The primary outcome measure is the Digit Span Test (DST). The secondary outcome measures are the Digit Symbol Substitution Test (DSST), Korean version of Montreal Cognitive Assessment (MoCA-K), Seoul Neuropsychological Screening Battery-II (SNSB-II), Beck Depression Inventory-II (BDI-II), State-Trait Anxiety Inventory (STAI), working memory (WM) task performance score, and structural/functional brain changes. Outcomes will be assessed at screening, baseline, 4 and 8 weeks, and after the end of treatment. We will also observe adverse events. In the statistical analysis, a full analysis set and per-protocol analysis will be performed.
DISCUSSION
CONCLUSIONS
This randomized clinical trial aims to examine the efficacy of acupuncture treatment for MCI. Neuropsychological tests, psychological inventories for measuring depression and anxiety, and magnetic resonance imaging will be performed to investigate the underlying neurological mechanisms and the association between cognition, emotion, and brain networks following acupuncture treatment. The results of the trial will provide evidence supporting the efficacy of acupuncture and also add to the neurobiological understanding of acupuncture treatment for MCI.
TRIAL REGISTRATION
BACKGROUND
Clinical Research Information Service, KCT0002896 . Registered on 25 May 2018.
Identifiants
pubmed: 31146774
doi: 10.1186/s13063-019-3446-9
pii: 10.1186/s13063-019-3446-9
pmc: PMC6543690
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
310Subventions
Organisme : Korea Institute of Oriental Medicine
ID : K18051
Références
J Clin Psychol. 1999 Jan;55(1):117-28
pubmed: 10100838
Arch Neurol. 1999 Mar;56(3):303-8
pubmed: 10190820
Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):534-40
pubmed: 10559571
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Psychon Bull Rev. 2005 Oct;12(5):769-86
pubmed: 16523997
Am J Epidemiol. 2007 Feb 1;165(3):344-50
pubmed: 17105962
Neuropsychology. 2007 Jul;21(4):458-69
pubmed: 17605579
Neuroimage. 2007 Oct 15;38(1):95-113
pubmed: 17761438
J Geriatr Psychiatry Neurol. 2008 Jun;21(2):104-10
pubmed: 18474719
Int J Geriatr Psychiatry. 2009 Feb;24(2):197-201
pubmed: 18850670
J Altern Complement Med. 2009 Mar;15(3):213-6
pubmed: 19250001
Int J Geriatr Psychiatry. 2010 Feb;25(2):191-201
pubmed: 19548273
J Korean Med Sci. 2010 Jul;25(7):1071-6
pubmed: 20592901
Int J Geriatr Psychiatry. 2011 Aug;26(8):812-7
pubmed: 20848576
Forsch Komplementmed. 2010 Oct;17(5):259-64
pubmed: 20980765
Neuropsychology. 2011 Mar;25(2):226-36
pubmed: 21090897
BMC Med. 2010 Nov 23;8:75
pubmed: 21092261
Dement Geriatr Cogn Disord. 2010;30(6):553-68
pubmed: 21252551
J Evid Based Med. 2010 Aug;3(3):140-55
pubmed: 21349059
Neuropsychology. 2011 Mar;25(2):237-48
pubmed: 21381828
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):171-3
pubmed: 22019547
Alzheimers Dement. 2012 Jan;8(1):14-21
pubmed: 22265588
PM R. 2012 May;4(5):367-73
pubmed: 22405683
Magn Reson Imaging. 2012 Jun;30(5):672-82
pubmed: 22459434
Aging Clin Exp Res. 2011 Oct-Dec;23(5-6):487-90
pubmed: 22526081
Pain. 2012 Sep;153(9):1852-62
pubmed: 22738796
PLoS One. 2012;7(8):e42730
pubmed: 22916152
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009132
pubmed: 22972133
Zhongguo Zhen Jiu. 2012 Sep;32(9):779-84
pubmed: 23227678
Evid Based Complement Alternat Med. 2013;2013:251603
pubmed: 23983775
CMAJ. 2013 Nov 5;185(16):1393-401
pubmed: 24043661
Acupunct Med. 2013 Dec;31(4):368-74
pubmed: 24123487
J Acupunct Meridian Stud. 2013 Oct;6(5):241-6
pubmed: 24139461
Dement Geriatr Cogn Dis Extra. 2013 Sep 28;3(1):320-32
pubmed: 24174927
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Dec;33(12):1626-30
pubmed: 24517058
J Intern Med. 2014 Mar;275(3):214-28
pubmed: 24605806
PLoS One. 2014 Jun 26;9(6):e99335
pubmed: 24968124
Neural Regen Res. 2014 Jun 1;9(11):1163-8
pubmed: 25206776
Age Ageing. 2015 Jan;44(1):25-33
pubmed: 25341676
Hum Brain Mapp. 2015 Mar;36(3):1217-32
pubmed: 25411150
Am J Psychiatry. 2015 Apr;172(4):323-34
pubmed: 25698435
Clin Interv Aging. 2015 Apr 10;10:687-93
pubmed: 25914527
Evid Based Complement Alternat Med. 2015;2015:529675
pubmed: 26064166
Curr Treat Options Neurol. 2015 Sep;17(9):372
pubmed: 26208489
Cereb Cortex. 2017 Jan 1;27(1):731-749
pubmed: 26543041
Biomed Res Int. 2015;2015:748212
pubmed: 26550575
J Integr Med. 2015 Nov;13(6):380-90
pubmed: 26559363
Korean J Fam Med. 2016 May;37(3):177-81
pubmed: 27274389
Acupunct Med. 2016 Oct;34(5):342-348
pubmed: 27491382
Br J Psychiatry. 2017 Jan;210(1):61-66
pubmed: 27758836
Neural Regen Res. 2017 Feb;12(2):250-258
pubmed: 28400807
Int J Geriatr Psychiatry. 2018 Feb;33(2):379-388
pubmed: 28731508
Dement Geriatr Cogn Disord. 2017;44(1-2):105-117
pubmed: 28768247
Dement Neuropsychol. 2015 Jul-Sep;9(3):301-305
pubmed: 29213976
Neurology. 2018 Jan 16;90(3):126-135
pubmed: 29282327
Front Neurosci. 2018 Jun 19;12:413
pubmed: 29970984
J Prev Alzheimers Dis. 2018;5(3):202-206
pubmed: 29972214
J Pers Assess. 1996 Dec;67(3):588-97
pubmed: 8991972